Login / Signup

Efficacy and Safety of Hou Gu Mi Xi on Spleen Qi Deficiency in Patients with Nonorganic Gastrointestinal Disorders: Protocol for a Multicenter, Randomized, Placebo-Controlled Trial.

Xiaofan ChenHeyun NieWenjun LiuYong FuJianhua NieBin XieDongping ChenYiping JiangKun-He ZhangYing FuDeping YangYan XiongZhangyang ZhaoXin SunWeifeng Zhu
Published in: Evidence-based complementary and alternative medicine : eCAM (2018)
The protocol was approved by Ethics Committee of five research hospitals and was registered in Clinicaltrials.gov (NCT03019042).
Keyphrases
  • double blind
  • placebo controlled
  • randomized controlled trial
  • clinical trial
  • public health
  • phase iii
  • healthcare
  • open label
  • study protocol
  • phase ii
  • replacement therapy
  • deep learning